Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

FDA clears potent pain reliever without opioid side effects from Wyeth-Ayerst

July 24, 1997

Naratriptan approved in 10 additional European countries

July 23, 1997

Schering AG describes AMPA antagonists

July 23, 1997

Toray/Daiichi codevelop analgesic

July 22, 1997

Maternal infection associated with increased risk for cerebral palsy in term infants

July 22, 1997

CoCensys to copromote Zarontin for pediatric epilepsy

July 21, 1997

VA-045 ameliorates head injury-induced neurological dysfunction

July 21, 1997

First report of kappa-opioid agonist efficacy in humans

July 21, 1997

FDA clears new indication and new labeling for Zoloft

July 18, 1997

New treatment options for ALS

July 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...